Meeder Asset Management Inc. Invests $56,000 in Inogen, Inc. (NASDAQ:INGN)

Meeder Asset Management Inc. bought a new stake in shares of Inogen, Inc. (NASDAQ:INGN) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 6,107 shares of the medical technology company’s stock, valued at approximately $56,000.

A number of other institutional investors have also recently added to or reduced their stakes in the business. AlphaQuest LLC purchased a new position in Inogen in the fourth quarter valued at about $43,000. Quarry LP acquired a new stake in Inogen during the 3rd quarter valued at $59,000. Ieq Capital LLC acquired a new stake in Inogen during the 4th quarter valued at $94,000. Intech Investment Management LLC purchased a new stake in Inogen during the 4th quarter worth $94,000. Finally, Verition Fund Management LLC acquired a new position in Inogen in the 3rd quarter worth $106,000. 89.94% of the stock is owned by hedge funds and other institutional investors.

Inogen Price Performance

NASDAQ INGN opened at $6.95 on Wednesday. The company has a market capitalization of $186.86 million, a price-to-earnings ratio of -3.09 and a beta of 1.16. Inogen, Inc. has a 12 month low of $6.14 and a 12 month high of $13.33. The company’s fifty day moving average price is $9.25 and its two-hundred day moving average price is $9.46.

Analysts Set New Price Targets

INGN has been the subject of several recent analyst reports. Needham & Company LLC restated a “hold” rating on shares of Inogen in a research note on Wednesday, February 26th. StockNews.com lowered Inogen from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th.

Inogen Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.